article thumbnail

Redefining clinical trials: Adopting AI for speed, volume and diversity

IBM Big Data Hub

Our analysis of the voluntarily reported Form FDA 1572 BMIS database reveals a potential lack of sustainability in the investigator pool, both in the United States (US) and globally (Exhibit 2). IBM is at the forefront of adopting AI for the pharmaceutical business, showcasing our commitment to refining this domain.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. As a starting point, determine whether the company qualifies as a business under the CCPA’s definition or if it may be subject to the CCPA by its relationships with for-profit businesses. Non-profit Exemption.

Privacy 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Data Intelligence and Its Role in Combating Covid-19

erwin

Privately it will come from hospitals, labs, pharmaceutical companies, doctors and private health insurers. These numerous data types and data sources most definitely weren’t designed to work together. Data lineage to support impact analysis. As a result, the data may be compromised, rendering faulty analyses and insights.

Metadata 122
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. As a starting point, determine whether the company qualifies as a business under the CCPA’s definition or if it may be subject to the CCPA by its relationships with for-profit businesses. Non-profit Exemption.

Privacy 40
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. As a starting point, determine whether the company qualifies as a business under the CCPA’s definition or if it may be subject to the CCPA by its relationships with for-profit businesses. Non-profit Exemption.

Privacy 40
article thumbnail

Regulatory Update: NAIC Summer 2021 National Meeting

Data Matters

Among other matters, the revised bond factors establish a more granular rating analysis by expanding the number of bond designation categories from the previous six categories to 20 categories. The passporting process is facilitated through the Reinsurance Financial Analysis (E) Working Group (ReFAWG).

article thumbnail

Law and Technology Move Center Stage

Positively RIM

While enabling quick delivery can be important, using algorithms for alerts to medical conditions or pharmaceutical needs can be life-saving. In the fourth (and possibly) final post on this conference, I will present a summary and analysis of the event as a whole. Why is Big Data significant for Information Governance?